MedTrace Logo

Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia

NCT01270490 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-02-14

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility and preliminary efficacy of interferon-gamma in combination with anidulafungin for the treatment of candidemia

Conditions

  • Candidemia

Interventions

DRUG

Interferon-gamma, Recombinant

Interferon 50 mcg/m2 to be administered three times per week during two weeks

Sponsors & Collaborators

  • BioMérieux

    collaborator INDUSTRY

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Mihai Netea, MD PhD · Radboud University Medical Center

  • Corine Delsing, MD · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01270490 on ClinicalTrials.gov